Chronopharmacology of Gemcitabine in the Treatment of Non-small Cell Lung Cancer
- VernacularTitle:吉西他滨治疗非小细胞肺癌的时辰药理学研究
- Author:
Jiao ZHONG
;
Wenyan ZHAO
;
Fulin WU
- Publication Type:Journal Article
- Keywords:
Gemcitabine;
Chronopharmacology;
Non-small cell lung cancer
- From:
China Pharmacy
1991;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05) but the incidence of toxicities in Group B was higher than in the other two groups. CONCLUSION:Comparatively speaking,Gemcitabine administered at 8 ∶ 00 was proved to be safer and more effective as compared with the other two groups in the treatment of NSCLC.
